Evidence map›Paper›PMID 22961080›Full record

ArticleDiabetes2013

A genome-wide association study identifies GRK5 and RASGRP1 as type 2 diabetes loci in Chinese Hans.

Huaixing Li, Wei Gan, Ling Lu, Xiao Dong, Xueyao Han, Cheng Hu, Zhen Yang, Liang Sun, Wei Bao, Pengtao Li and 30 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 9 pooled it
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 9 syntheses or guidelines pooled it, 184 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Acta biochimica et biophysica Sinica · 2024
    Article
  19. Review
  20. Review

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors at 16 institutions in 2 countries.

Huaixing LiKey Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and Graduate School of the Chinese Academy of Sciences, Shanghai, China.
Wei Gan
Ling Lu
Xiao Dong
Xueyao Han
Cheng Hu
Zhen Yang
Liang Sun
Wei Bao
Pengtao Li
Meian He
Liangdan Sun
Yiqin Wang
Jingwen Zhu
Qianqian Ning
Yong Tang
Rong Zhang
Jie Wen
Di Wang
Xilin Zhu
Kunquan Guo
Xianbo Zuo
Xiaohui Guo
Handong Yang
Xianghai Zhou
DIAGRAM Consortium
AGEN-T2D Consortium
Xuejun Zhang
Lu Qi
Ruth J F Loos
Frank B Hu
Tangchun Wu
Ying Liu
Liegang Liu
Ze Yang
Renming Hu
Weiping Jia
Linong Ji
Yixue Li
Xu Lin
Chinese Academy of Sciences · CNHuazhong University of Science and Technology · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNPeking University · CNShanghai Institutes for Biological Sciences · CNAnhui Medical University · CNFudan University · CNHuashan Hospital · CNShanghai Jiao Tong University · CNBeijing Hospital · CNDongfeng Motor (China) · CNIcahn School of Medicine at Mount Sinai · USMinistry of Education of the People's Republic of China · CNPeking University First Hospital · CNPeking University People's Hospital · CNShanghai Sixth People's Hospital · CN

Funding

Medical Research Council MC_U106188470Wellcome Trust 090532Wellcome Trust 098017
6 · The paper itself

Abstract

Substantial progress has been made in identification of type 2 diabetes (T2D) risk loci in the past few years, but our understanding of the genetic basis of T2D in ethnically diverse populations remains limited. We performed a genome-wide association study and a replication study in Chinese Hans comprising 8,569 T2D case subjects and 8,923 control subjects in total, from which 10 single nucleotide polymorphisms were selected for further follow-up in a de novo replication sample of 3,410 T2D case and 3,412 control subjects and an in silico replication sample of 6,952 T2D case and 11,865 control subjects. Besides confirming seven established T2D loci (CDKAL1, CDKN2A/B, KCNQ1, CDC123, GLIS3, HNF1B, and DUSP9) at genome-wide significance, we identified two novel T2D loci, including G-protein-coupled receptor kinase 5 (GRK5) (rs10886471: P = 7.1 × 10(-9)) and RASGRP1 (rs7403531: P = 3.9 × 10(-9)), of which the association signal at GRK5 seems to be specific to East Asians. In nondiabetic individuals, the T2D risk-increasing allele of RASGRP1-rs7403531 was also associated with higher HbA(1c) and lower homeostasis model assessment of β-cell function (P = 0.03 and 0.0209, respectively), whereas the T2D risk-increasing allele of GRK5-rs10886471 was also associated with higher fasting insulin (P = 0.0169) but not with fasting glucose. Our findings not only provide new insights into the pathophysiology of T2D, but may also shed light on the ethnic differences in T2D susceptibility.

Indexed as

Genetic LociGenome-Wide Association StudyPolymorphism, Single NucleotideAdiposityBlood GlucoseChinaDiabetes Mellitus, Type 2DNA-Binding ProteinsGenetic Predisposition to DiseaseG-Protein-Coupled Receptor Kinase 5Guanine Nucleotide Exchange FactorsHumansLinkage DisequilibriumQuantitative Trait LociBlood GlucoseDNA-Binding ProteinsG-Protein-Coupled Receptor Kinase 5GRK5 protein, humanGuanine Nucleotide Exchange FactorsRASGRP1 protein, human

Identifiers

PMID22961080
PMCPMC3526061
OpenAlexW2118615260

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.